argenx’s Post

We've built the first truly multimodal real-world clinical dataset purpose-built to capture the underlying biology of cardiometabolic diseases, including the role of GLP-1s in treatment. This dataset is designed to help drug developers and researchers: ▶ Understand the patient journey for those on GLP-1s ▶ Quantify any side effects associated with GLP-1 use ▶ Demonstrate therapeutic effects beyond intended use including secondary benefits derived from additional modalities and exploratory use ▶ Compare efficacy of products that were never studied head-to-head across a range of different real-world measures ▶ Develop precision medicine tools that identify patients with uncontrolled symptoms and/or match patients to the right treatments Our data go deep: drawing in imaging, waveforms, notes, pathology, and videos linked to long-term outcomes from the EHR for GLP-1 users and matched control groups. We'll be at the GLP-1 Based Therapeutics Summit on May 15-16, 2024 in Philadelphia, PA to meet and learn from others who are working in this space. We hope to see you there! Schedule a time to chat: https://lnkd.in/g23jwAf5 See the full agenda: https://ter.li/86n56l Visit our GLP-1 page: https://lnkd.in/g4AuzutP

Curious about the latest trends in medical laboratory science? Stay Connected and Informed with LabRoots! LabRoots, a leading scientific social networking site, offers resources for MLS professionals looking to expand their knowledge and connect with industry experts. Engage with cutting-edge webinars and virtual events covering a wide array of topics from microbiology to laboratory technology. LabRoots makes it easy with access to the latest scientific research and educational content. Whether you're diving into infectious diseases or exploring new diagnostic techniques, there’s something here to enhance every aspect of your professional journey. Excited to learn and connect with other lab professionals? What topics are you most interested in exploring further? https://www.labroots.com/ #laboratory #medicallaboratory #biomedicalscience

Human Immunome Project is taking action now so that, someday soon, humanity will hold the keys to understanding the inner workings of the immune system. Today, on this #DayofImmunology, take a moment to familiarize yourself with our plan.

Attended the Organoid Conference in Cambridge, where the research highlighted the significant potential of organoids in preclinical studies. Organoids are powerful tools for modeling human diseases and testing treatments accurately. They play a crucial role in drug screening, disease modeling, and understanding disease mechanisms. Such conferences are invaluable for staying at the forefront of research and are crucial for my career development in the field. #OrganoidResearch #PreclinicalStudies

Learn to collaborate. David Simon, PhD, a 2007 graduate of our Microbiology and Immunology program, says graduate school will introduce you to diverse groups of people with differing opinions. Embrace this diversity and learn how to work harmoniously with everyone. It's essential to understand how to disagree without being disagreeable. The key is to foster an environment of discussion, debate, and, sometimes, dissension but always in a productive manner. Check out the full conversation with David: https://urmc.info/1gG

Did you miss the #webinar where Robin Bombardi, Goran Marinković and I talked about Navigating the immune repertoire? You can still sign up through the original link and view the recording. And if you have questions that you didn't ask us during the webinar, drop us a note! #coolstuff #betterlatethannever #repseq #bcr #tcr #repertoire #immunomics #antibody #AIRR

Improving therapy initiation and the patient experience is challenging – but not impossible. Partnering with AllazoHealth, a leading immunology biologic therapy manufacturer was empowered to completely transform its patient support program, delivering astonishing operational efficiency and first-fill rate increases. To discover the complete set of results, watch the video below. . . . #PharmaMarketing #PatientExperience #PersonalizationNotPersonas #PatientInterventions #MedicationAdherence #AI #PatientEngagement #PatientSupportPrograms

Excited to share our latest publication on "Plant-derived Immunomodulators: Preclinical and Clinical Trial Progression." This comprehensive review highlights the therapeutic potential of plant-derived immunostimulants and immunosuppressants, their bioactive components, and underlying mechanisms. Grateful to my co-authors and collaborators for their invaluable contributions. Dive into the paper to explore how plant-based compounds are paving the way for safer and more effective immunotherapies! #Research #Immunology #Phytochemicals #ClinicalTrials #PlantMedicine #DrugDevelopment #HealthcareInnovation

🔗 https://lnkd.in/eCpJdC4q The #LaboratoryDevelopedTesting (#LDT) Market was valued at US$ 5.14 Bn in 2023 and is expected to reach USD 8.58 Bn by 2030, exhibiting a CAGR of 7.58% during the forecast period 2024-2030. 🔬 LDT Market Dynamics: 🧪 Development and Operation: LDTs are developed and implemented in clinical labs to meet unmet analytical and clinical care needs Most FDA-cleared assays are not commercially available, incompatible with lab instruments, or don't meet specific performance standards Labs consolidate around a few instrument vendors to offer a wide range of FDA-cleared assays for their patient demographics 🔍 Role in Diagnostic Innovation: LDTs play a crucial role in diagnostic innovation, especially in academic and university clinical labs Used in cancer diagnosis, identifying mutations for additional therapeutic options, characterizing genetic mutations in inheritable diseases, and diagnosing/treating infectious diseases In many cases, no FDA-approved or certified alternatives are available 🌐 Prevalence and Expertise: LDTs are routinely established in academic clinical labs and reference labs Reference labs develop LDTs to address unmet clinical needs and rare diseases due to high costs of premarket approval Clinical pathologists, lab scientists, and staff gain expertise through direct experience, information sharing, publications, and conferences, leading to LDT development #Diagnostics #ClinicalLabs #MolecularDiagnostics #Oncology #Genetics #InfectiousDiseases #HealthcareTechnology #MarketResearch #IndustryTrends

Stanford University School of Medicine recent study can help reverse the usual age-related debilitating muscle loss that impacts millions of people over the age of 50 every year and that significantly affects the quality of life thereafter. Could this drug radically change the onset of the dreadful aches and pains which usually tag along with age? Watch the groundbreaking study and promising results to take a look at the future for humans. #standforduniversity #standforduniversityofmedicine #musclebuilding #musclehealth #agerelatedillness #restoringmuscleweakness #musclemass #musclegrowth